Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 09:16 am Unchanged |
2025-04-16 | 13D | Elevation Oncology, Inc. ELEV |
BML Investment Partners, L.P. | 5,890,934 9.900% |
0 (Unchanged) |
Filing History |
| 2025-03-26 7:11 pm Purchase |
2025-03-21 | 13G | Elevation Oncology, Inc. ELEV |
BML Investment Partners, L.P. | 5,890,934 9.900% |
5,890,934 (New Position) |
Filing History |
| 2025-02-14 1:34 pm Sale |
2024-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Logos Global Management LP | 0 0.000% |
-3,500,000 (Position Closed) |
Filing History |
| 2025-02-06 2:52 pm Sale |
2024-12-31 | 13G | Elevation Oncology, Inc. ELEV |
GOLDMAN SACHS GROUP INC GS |
1,683,356 2.800% |
-2,833,221 (-62.73%) |
Filing History |
| 2025-02-05 4:28 pm Unchanged |
2024-12-31 | 13G | Elevation Oncology, Inc. ELEV |
FARALLON CAPITAL PARTNERS LP | 3,527,482 6.000% |
0 (Unchanged) |
Filing History |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Elevation Oncology, Inc. ELEV |
BLACKROCK INC BLK |
3,163,180 5.400% |
3,163,180 (New Position) |
Filing History |
| 2025-01-30 9:33 pm Sale |
2024-12-31 | 13G | Elevation Oncology, Inc. ELEV |
The Vanguard Group | 2,610,045 4.410% |
-461,535 (-15.03%) |
Filing History |
| 2024-11-14 7:50 pm Sale |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
Point72 Asset Management, L.P. | 500,000 0.800% |
-3,540,000 (-87.62%) |
Filing History |
| 2024-11-14 7:05 pm Sale |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
Logos Global Management LP | 3,500,000 5.900% |
-150,000 (-4.11%) |
Filing History |
| 2024-11-14 6:45 pm Sale |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
ORBIMED ADVISORS LLC | 2,441,275 4.000% |
-558,725 (-18.62%) |
Filing History |
| 2024-11-14 4:46 pm Sale |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
GREAT POINT PARTNERS LLC | 0 0.000% |
-3,877,172 (Position Closed) |
Filing History |
| 2024-11-14 4:28 pm Purchase |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
BIOTECHNOLOGY VALUE FUND L P | 6,230,845 9.990% |
1,779,960 (+39.99%) |
Filing History |
| 2024-11-12 4:26 pm Purchase |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
Aisling Capital IV LP | 2,913,005 4.920% |
34,709 (+1.21%) |
Filing History |
| 2024-11-12 2:22 pm Unchanged |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
The Vanguard Group | 3,071,580 5.190% |
0 (Unchanged) |
Filing History |
| 2024-11-08 11:54 am Purchase |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
FARALLON CAPITAL PARTNERS LP | 3,527,482 6.000% |
427,482 (+13.79%) |
Filing History |
| 2024-11-06 2:40 pm Purchase |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
GOLDMAN SACHS GROUP INC GS |
4,516,577 7.600% |
4,516,577 (New Position) |
Filing History |
| 2024-11-04 11:49 am Purchase |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
The Vanguard Group | 3,071,580 5.190% |
3,071,580 (New Position) |
Filing History |
| 2024-10-09 09:01 am Unchanged |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
Empery Asset Management, LP | 4,000,000 4.990% |
0 (Unchanged) |
Filing History |
| 2024-08-15 4:03 pm Purchase |
2024-08-06 | 13G | Elevation Oncology, Inc. ELEV |
GREAT POINT PARTNERS LLC | 3,877,172 6.560% |
3,877,172 (New Position) |
Filing History |
| 2024-08-08 9:05 pm Sale |
2024-08-08 | 13D | Elevation Oncology, Inc. ELEV |
venBio Global Strategic Fund III L.P. | 2,031,920 3.400% |
-505,851 (-19.93%) |
Filing History |